News

Colorectal cancer evades immunotherapy using a dual barrier

FDA approves daratumumab and hyaluronidase-fihj for high-risk smouldering multiple myeloma

Combination immunotherapy helps overcome melanoma treatment resistance

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

Hidden HPV-linked cell type may drive early cervical cancer

Additional testing can improve kidney cancer diagnosis

New cancer drug shows exceptional tumour-fighting potential

RNA modification m⁶A emerges as key player in cancer development and therapy

Abnormal transport signal on mutant UBTF gene drives high-risk acute myeloid leukaemia

New clinical trial studies impact of exercise on cancer patients

New study uncovers potential way to prevent breast cancer in pre-menopausal women

Supervised exercise improves strength and physical performance in patients with advanced breast cancer